Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

Evaluating Hypericin as a Therapeutic Agent Against Neisseria gonorrhoeae

Version 1 : Received: 9 February 2024 / Approved: 12 February 2024 / Online: 12 February 2024 (05:35:59 CET)

How to cite: Ferrari, I. V. Evaluating Hypericin as a Therapeutic Agent Against Neisseria gonorrhoeae. Preprints 2024, 2024020636. https://doi.org/10.20944/preprints202402.0636.v1 Ferrari, I. V. Evaluating Hypericin as a Therapeutic Agent Against Neisseria gonorrhoeae. Preprints 2024, 2024020636. https://doi.org/10.20944/preprints202402.0636.v1

Abstract

Neisseria gonorrhoeae is a bacterium that causes the sexually transmitted infection gonorrhea. This study employed molecular docking simulations to investigate potential interactions between natural molecules and the Fe(3+) ions import ATP-binding protein fbpC in Neisseria gonorrhoeae FA 1090. Among the screened molecules, Hypericin exhibited a remarkable binding energy of approximately -13.2 kcal/mol, indicating a robust and favorable binding affinity with the target protein. This promising outcome suggests that Hypericin could serve as a potential candidate for further exploration as a therapeutic agent against Neisseria gonorrhoeae infections. However, it is imperative to emphasize that these in silico findings necessitate experimental validation through in vitro and in vivo studies to ascertain the actual efficacy and safety of Hypericin as a treatment option.

Keywords

Hypericin; Neisseria gonorrhoeae; Docking analysis; Autodock Vina

Subject

Public Health and Healthcare, Public, Environmental and Occupational Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.